Title |
Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1)
|
---|---|
Published in |
Breast Cancer Research and Treatment, April 2019
|
DOI | 10.1007/s10549-018-05081-z |
Pubmed ID | |
Authors |
Luis Baez-Vallecillo, Akshara S. Raghavendra, Kenneth R. Hess, Carlos H. Barcenas, Stacy L. Moulder, Debu Tripathy, Vicente Valero, Rashmi K. Murthy |
Mendeley readers
The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 41 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 8 | 20% |
Other | 6 | 15% |
Student > Ph. D. Student | 5 | 12% |
Student > Bachelor | 4 | 10% |
Lecturer | 2 | 5% |
Other | 3 | 7% |
Unknown | 13 | 32% |
Readers by discipline | Count | As % |
---|---|---|
Pharmacology, Toxicology and Pharmaceutical Science | 11 | 27% |
Medicine and Dentistry | 8 | 20% |
Economics, Econometrics and Finance | 4 | 10% |
Biochemistry, Genetics and Molecular Biology | 1 | 2% |
Nursing and Health Professions | 1 | 2% |
Other | 0 | 0% |
Unknown | 16 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 April 2019.
All research outputs
#20,566,010
of 23,142,049 outputs
Outputs from Breast Cancer Research and Treatment
#4,136
of 4,691 outputs
Outputs of similar age
#303,130
of 353,223 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#63
of 70 outputs
Altmetric has tracked 23,142,049 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,691 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,223 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 70 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.